OPTIMIzing muScle Preservation in paTients wIth Cirrhosis
NCT05367596 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2023-02-09
Summary
Patients with obesity and cirrhosis benefit from weight loss but are prone to sarcopenia (loss of muscle mass, strength, and function).
This study proposes to test a specialized weight loss program Alternative-day Modified Fasting (ADMF) designed to promote weight loss and preserve skeletal muscle mass, strength, and function in patients with both Child-Pugh (CP) class A cirrhosis and obesity. This study will compare the effectiveness of the ADMF to Continuous Energy Restriction (CER) for 24-weeks. Both arms will receive a high-protein, high-BCAA diet, a late-night snack, supervised aerobic and resistance exercise, increased physical activity through self-monitoring, and group behavioral counseling.
The primary aim of this trial is to evaluate the feasibility and acceptability of ADMF and CER for 6 months in patients with cirrhosis and obesity. The secondary aim is to compare changes in body composition in both diets.
Conditions
- Obesity
- Compensated Cirrhosis
- Sarcopenia
Interventions
- BEHAVIORAL
-
Continuous Energy Restriction (CER)
Energy intake will be prescribed at approximately 1,200-1,500 kcal/day with high protein. The diet will consist of low-calorie shakes provided by the study, as well as commercially available portion-controlled entrées, fruits/vegetables, and low energy-density foods available in grocery stores.
- BEHAVIORAL
-
Alternate Day Modified Fasting (ADMF)
Enhanced Care participants will have an alternate between three days of very-low energy intake (VLED; approximately 600-800 kcal/d) and four days of healthy eating (HE) each week. On HE days, participants will consume foods ad libitum for satiety.
- BEHAVIORAL
-
Group Health Education Sessions
Using video conferencing, all participants will attend weekly approximately 45-60 minutes group health education sessions led by a registered dietitian. The session will deliver a comprehensive nutritional and lifestyle change program to promote lifestyle changes and improve compliance.
- BEHAVIORAL
-
Late Evening Snack
The participants will have a late evening snack with a protein supplement.
- BEHAVIORAL
-
Physical activity
All participants will be prescribed moderate-intensity aerobic activities that do not require access to specialized exercise facilities.
- BEHAVIORAL
-
Self-monitoring
Weekly data related to adherence, food intake, physical activity, weight measurement, and nonserious adverse events will be self-reported via a REDCap survey. Participants will also be provided with a wireless activity tracker to measure total physical activity and intensity of activity objectively. These data will be used to counsel participants in addition to providing valuable feasibility data.
- BEHAVIORAL
-
Remotely Supervised Exercise Sessions
Sessions of 45 minutes duration will be delivered via video conferencing 2-3 times per week.
Sponsors & Collaborators
-
University of Kansas Medical Center
lead OTHER
Principal Investigators
-
Winston Dunn, MD · KUMC
-
Felicia Felicia Steger, PhD · KUMC
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-06-22
- Primary Completion
- 2022-12-16
- Completion
- 2022-12-16
Countries
- United States
Study Locations
More Related Trials
-
Evaluation of Diet and Exercise in Patients With Non-Alcoholic Fatty Liver Disease
NCT00815009 ·Status: COMPLETED ·Phase: NA
-
Vigorous- Versus Moderate-intensity Exercise to Reduce Liver Fat in Adults With Obesity and NAFLD
NCT06124456 ·Status: RECRUITING ·Phase: NA
-
Weight Management in Nonalcoholic Steatohepatitis
NCT00266019 ·Status: COMPLETED ·Phase: PHASE2
-
Alternate Day Fasting, Exercise, and NAFLD
NCT04004403 ·Status: COMPLETED ·Phase: NA
-
Sarcopenic Obesity in the Elderly
NCT06083909 ·Status: COMPLETED
-
Alternate Day Fasting and Exercise in Overweight or Obese Adults
NCT03652532 ·Status: COMPLETED ·Phase: NA
-
Optimal Exercise Frequency to Reduce Liver Fat in Centrally Obese Adults With Non-Alcoholic Fatty Liver Disease
NCT05741957 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluation of the Effectiveness of a Comprehensive Visceral Adiposity-Focused Anti-Obesity Program
NCT04807959 ·Status: COMPLETED
-
Intermittent Fasting in Nonalcoholic Fatty Liver Disease
NCT04355910 ·Status: UNKNOWN ·Phase: NA
-
Relative Sarcopenia and Cardiometabolic Risk in Young Adults With Obesity
NCT04195061 ·Status: COMPLETED
-
Sedentary Postmenopausal Women With Nonalcoholic Fatty Liver Disease (NAFLD) Submitted to Physical Activity
NCT02427087 ·Status: COMPLETED ·Phase: NA
-
Prebiotic Fibre Supplementation and Gut Microbiota in Non-alcoholic Fatty Liver Disease
NCT02568605 ·Status: COMPLETED ·Phase: NA
-
Assessment of Body Composition and Physical Function
NCT05784571 ·Status: COMPLETED
-
Effects of Time-restricted Hypocaloric Diet in Patients with NAFLD
NCT05866744 ·Status: COMPLETED ·Phase: NA
-
A Community-based Prospective Cohort Study on Metabolic Dysfunction-Associated Fatty Liver Disease in Older Adults: From Metabolic Trajectories to Extrahepatic Outcomes
NCT07241195 ·Status: NOT_YET_RECRUITING
-
A Phase II Study of the Effect of a Low Calorie Diet on Patients Undergoing Liver Resection
NCT01645852 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Mechanisms of Sarcopenia in Chronic Inflammatory Disease: Protocol for a Prospective Cohort Study
NCT04734496 ·Status: UNKNOWN
-
Characterization of Gut Microbiota in Chronic Liver Disease With Decreased Muscle Mass
NCT05729269 ·Status: COMPLETED
-
Exercise Study in Subjects With NAFLD
NCT03995056 ·Status: COMPLETED ·Phase: NA
-
Effects of Weight Loss on Portal Pressure in Patients With Overweight/Obesity and Cirrhosis
NCT01409356 ·Status: COMPLETED ·Phase: PHASE2
-
Lifestyle Interventions for the Treatment of Non-alcoholic Fatty Liver Disease in Overweight and Obese Adults
NCT03972631 ·Status: UNKNOWN ·Phase: NA
-
Non-Alcoholic Fatty Liver Disease and Anthropometric Measurements
NCT05810506 ·Status: COMPLETED
-
Effect of Modified Time-restricted Feeding in Preventing Progression of Non-Alcoholic Fatty Liver Disease (NAFLD).
NCT03848390 ·Status: UNKNOWN ·Phase: NA
-
Different Exercise Modalities in the Treatment of NAFLD and Their Impact on Myokines
NCT06257732 ·Status: RECRUITING ·Phase: NA
-
Hepatic and Cardiac Metabolic Flexibility in Obese With NAFLD.
NCT03583437 ·Status: COMPLETED ·Phase: NA